Active substances
Chlorphenamine + Paracetamol + Pseudoephedrine
- SFDA 7
- Health Canada 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ADOL ALLERGY SINUS 325MG-2MG-30MG CAPLET | 325,30,2 mg,mg,mg | Tablet · Oral use | 24 Blister | SAR 10.90 | NCE · OTC | Gulf Pharmaceutical Industries (Julphar) | Valid |
| FEVADOL COLD & FLU TABLETS | 500,30,2 mg,mg,mg | Tablet · Oral use | 30 Blister | SAR 15.00 | Generic · OTC | SPIMACO ADDWAEIH | Valid |
| FLUDREX SYRUP | 120,15,0.75 mg,mg,mg | Syrup · Oral use | 1 Bottle | SAR 12.00 | Generic · OTC | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| FLUDREX SYRUP | 1440,180,9 mg,mg,mg | Syrup · Oral use | 1 Bottle | SAR 2.90 | Generic · OTC | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| PANADOL COLD & FLU CAPLET | 500,30,2 mg,mg,mg | Tablet · Oral use | 24 Blister | SAR 12.30 | Generic · OTC | Haleon Australia Pty Ltd | Valid |
| EMIDOL COLD SYRUP | 24,3,0.4 mg,mg,mg | Syrup · Oral use | 1 Bottle | SAR 4.00 | Generic · OTC | GLOBAL PHARMA | Withdrawn by MAH · Not Marketed |
| FLUDREX SINUS CAPLETS | 416.6 , 3 , 30 mg | Tablet · Oral use | 24 Blister | SAR 7.10 | Generic · OTC | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Withdrawn by MAH · Not Marketed |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| CHILDREN'S TYLENOL COLD | 02039982 | 1 MG / 5 ML; 15 MG / 5 ML; 160 MG / 5 ML | SUSPENSION · ORAL | KENVUE CANADA INC. |
| EXTRA STRENGTH ALLERGY SINUS MEDICATION | 02159546 | 2 MG; 30 MG; 500 MG | TABLET · ORAL | VITA HEALTH PRODUCTS INC |
| EXTRA STRENGTH SINUTAB SINUS & ALLERGY | 01986988 | 2 MG; 30 MG; 500 MG | TABLET · ORAL | KENVUE CANADA INC. |
| EXTRA STRENGTH TYLENOL COLD & SINUS NIGHTTIME | 02348098 | 2 MG; 30 MG; 500 MG | TABLET · ORAL | KENVUE CANADA INC. |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.